Prevalence and antimicrobial resistance of Enterococcus species: A hospital-based study in China

International Journal of Environmental Research and Public Health

Volumn 11, Issue 3, 2014, Pages 3424-3442

  Jia, Wei ^a   Li, Gang ^a   Wang, Wen ^a  

^a NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Active efflux mechanism; Antimicrobial resistance; Enterococcus spp.; Fluoroquinolones; Reserpine

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; DALFOPRISTIN; ERYTHROMYCIN; FOSFOMYCIN; GATIFLOXACIN; GENTAMICIN; LEVOFLOXACIN; LINEZOLID; MINOCYCLINE; NITROFURANTOIN; PENICILLIN DERIVATIVE; QUINUPRISTIN; RESERPINE; RIFAMPICIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL DISEASE; BACTERIUM; DISEASE CONTROL; DISEASE PREVALENCE; DRUG; INFECTIOUS DISEASE;

AAC(6')-APH(2'') GENE; ANT(2'')-I GENE; ANT(6)-I GENE; ANTIBIOTIC RESISTANCE; APH(3')-III GENE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CHINA; EMEA GENE; ENTEROCOCCUS; ENTEROCOCCUS AVIUM; ENTEROCOCCUS CASSELIFLAVUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ERMB GENE; HOSPITAL; HOSPITAL DEPARTMENT; NONHUMAN; PREVALENCE; TEM GENE; TETM GENE; VANA GENE; GENETICS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMAN; MICROBIAL SENSITIVITY TEST; MULTIDRUG RESISTANCE;

CHINA;

CHINA; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; RESERPINE;

EID: 84897852267     PISSN: 16617827     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph110303424     Document Type: Article

References (57)

1. Jarvis, W.R.; Martone, W.J. Predominant pathogens in hospital infections. J. Antimicrob. Chemother. 1992, 29, 19-24.
2. Sood, S.; Malhotra, M.; Das, B.K.; Kapil, A. Enterococcal infections & antimicrobial resistance. Indian J. Med. Res. 2008, 128, 111-121.
3. Bonten, M.J.; Willems, R.; Weinstein, R.A. Vancomycin-resistant enterococci: Why are they here, and where do they come from? Lancet Infect. Dis. 2001, 1, 314-325.
4. Adhikari, L. High-level aminoglycoside resistance and reduced susceptibility to vancomycin in nosocomial enterococci. J. Glob. Infect. Dis. 2010, 2, 231-235.
5. Cetinkaya, Y.; Falk, P.; Mayhall, C.G. Vancomycin-resistant enterococci. Clin. Microbiol. Rev. 2000, 13, 686-707.
6. Biemer, J.J. Antimicrobial susceptibility testing by the Kirby-Bauer disc diffusion method. Ann. Clin. Lab. Sci. 1973, 3, 135-140.
7. Tsaur, S.M.; Chang, S.C.; Luh, K.T.; Hsieh, W.C. Antimicrobial susceptibility of enterococci in vitro. J. Formos. Med. Assoc. 1993, 92, 547-552.
8. Shay, D.K.; Goldmann, D.A.; Jarvis, W.R. Reducing the spread of antimicrobial-resistant microorganisms. Control of vancomycin-resistant enterococci. Pediatr. Clin. North. Am. 1995, 42, 703-716.
9. Klare, I.; Konstabel, C.; Badstübner, D.; Werner, G.; Witte, W. Occurrence and spread of antibiotic resistances in Enterococcus faecium. Int. J. Food. Microbiol. 2003, 88, 269-290.
10. Miranda, G.; Lee, L.; Kelly, C.; Solórzano, F.; Leaños, B.; Muñoz, O.; Patterson, J.E. Antimicrobial resistance from enterococci in a pediatric hospital. Plasmids in Enterococcus faecalis isolates with high-level gentamicin and streptomycin resistance. Arch. Med. Res. 2001, 32, 159-163.
11. Udo, E.E.; Al-Sweih, N.; Phillips, O.A.; Chugh, T.D. Species prevalence and antibacterial resistance of enterococci isolated in Kuwait hospitals. J. Med. Microbiol. 2003, 52, 163-168.
12. Salem-Bekhit, M.M.; Moussa, I.M.; Muharram, M.M.; Alanazy, F.K.; Hefni, H.M. Prevalence and antimicrobial resistance pattern of multidrug-resistant enterococci isolated from clinical specimens. Indian J. Med. Microbiol. 2012, 30, 44-51.
13. Maschieto, A.; Martinez, R.; Palazzo, I.C.; Darini, A.L. Antimicrobial resistance of Enterococcus sp. isolated from the intestinal tract of patients from a university hospital in Brazil. Mem. Inst. Oswaldo Cruz 2004, 99, 763-767.
14. Ling, J.M.; Char, T.S.; Cheng, A.F. Distribution of enterococci in Hong Kong. J. Infect. 2002, 45, 257-262.
15. Lu, J.F.; Qian, L.; Huo, J.F.; Shao, K.Y. Clinical distribution and drug sensitivity analysis of 302 strains of Enterococcus. Med. Pharm. J. Chin. PLA. 2011, 23, 42-43.
16. Guo, Z.S.; Zhang, L.H.; Lin, S.S. Analysis of the isolation and variance of resistance to antibiotics of Enterococcus in blood specimens. Lab. Med. Clin. 2012, 9, 537-539.
17. Qian, Y.H.; Guo, J.W.; Ma, C.; Hao, X.H.; Liu, L.J.; Li, Y.J.; Ma, X.B. Distribution and antibiotics sensitivity status of 243 strains of enterococcus from clinical samples. Chin. J. Nosocomiol. 2011, 21, 1892-1894.
18. Liu, Y.; Huang, W.X.; Dong, Y.S.; Jia, B.; Zheng, X.P.; Liu, C.W.; Yu, D.G.; Li, C.Z. Antimicrobial susceptibility of Enterococci isolated from the first affiliated hospital of Chongqing Medical University during 2006-2009. Chin. J. Antibiot. 2010, 35, 703-706.
19. Xiao, Y.H.; Wang, J.; Li, Y.; MOH National Antimicrobial Resistance Investigation Net. Bacterial resistance surveillance in China: A report from Mohnarin 2004-2005. Eur. J. Clin. Microbiol. Infect. Dis. 2008, 27, 697-708.
20. Hollenbeck, B.L.; Rice, L.B. Intrinsic and acquired resistance mechanisms in enterococcus. Virulence. 2012, 3, 421-433.
21. Arias, C.A.; Murray, B.E. The rise of the Enterococcus: Beyond vancomycin resistance. Nat. Rev. Microbiol. 2012, 10, 266-278.
22. Arias, C.A.; Contreras, G.A.; Murray, B.E. Management of multidrug-resistant enterococcal infections. Clin. Microbiol. Infect. 2010, 16, 555-562.
23. Arias, C.A.; Murray, B.E. Emergence and management of drug-resistant enterococcal infections. Expert. Rev. Anti. Infect. Ther. 2008, 6, 637-655.
24. Huycke, M.M.; Sahm, D.F.; Gilmore, M.S. Multiple-drug resistant enterococci: The nature of the problem and an agenda for the future. Emerg. Infect. Dis. 1998, 4, 239-249.
25. Hammerum, A.M.; Lester, C.H.; Heuer, O.E. Antimicrobial-resistant enterococci in animals and meat: A human health hazard? Foodborne. Pathog. Dis. 2010, 7, 1137-1146.
26. El-Khoury, J.; Fishman, J.A. Linezolid in the treatment of vancomycin-resistant Enterococcus faecium in solid organ transplant recipients: Report of a multicenter compassionate-use trial. Transpl. Infect. Dis. 2003, 5, 121-125.
27. Moellering, R.C. Quinupristin/dalfopristin: Therapeutic potential for vancomycin-resistant enterococcal infections. J. Antimicrob. Chemother. 1999, 44, 25-30.
28. Moellering, R.C.; Linden, P.K.; Reinhardt, J.; Blumberg, E.A.; Bompart, F.; Talbot, G.H. The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium. Synercid Emergency-Use Study Group. J. Antimicrob. Chemother. 1999, 44, 251-261.
29. Winston, D.J.; Emmanouilides, C.; Kroeber, A.; Hindler, J.; Bruckner, D.A.; Territo, M.C.; Busuttil, R.W. Quinupristin/Dalfopristin therapy for infections due to vancomycin-resistant Enterococcus faecium. Clin. Infect. Dis. 2000, 30, 790-797.
30. Linden, P. Quinupristin-dalfopristin. Curr. Infect. Dis. Rep. 1999, 1, 480-487.
31. Manzella, J.P. Quinupristin-dalfopristin: A new antibiotic for severe gram-positive infections. Am. Fam. Physician. 2001, 64, 1863-1866.
32. Schouten, M.A.; Hoogkamp-Korstanje, J.A. Comparative in vitro activities of quinupristin-dalfopristin against Gram-positive bloodstream isolates. J. Antimicrob. Chemother. 1997, 40, 213-219.
33. Hershberger, E.; Donabedian, S.; Konstantinou, K.; Zervos, M.J. Quinupristin-dalfopristin resistance in gram-positive bacteria: Mechanism of resistance and epidemiology. Clin. Infect. Dis. 2004, 38, 92-98.
34. Hayes, J.R.; McIntosh, A.C; Qaiyumi, S.; Johnson, J.A.; English, L.L.; Carr, L.E.; Wagner, D.D.; Joseph, S.W. High-frequency recovery of quinupristin-dalfopristin-resistant Enterococcus faecium isolates from the poultry production environment. J. Clin. Microbiol. 2001, 39, 2298-2299.
35. McDonald, L.C.; Rossiter, S.; Mackinson, C.; Wang, Y.Y.; Johnson, S.; Sullivan, M.; Sokolow, R.; DeBess, E.; Gilbert, L.; Benson, J.A. et al. Quinupristin-dalfopristin-resistant Enterococcus faecium on chicken and in human stool specimens. N. Engl. J. Med. 2001, 345, 1155-1160.
36. Soltani, M.; Beighton, D.; Howard, J.P.; Woodford, N. Mechanisms of resistance to quinupristin-dalfopristin among isolates of Enterococcus faecium from animals, raw meat, and hospital patients in western Europe. Antimicrob. Agents. Chemother. 2000, 44, 433-436.
37. Luh, K.T.; Hsueh, P.R.; Teng, L.J.; Pan, H.J.; Chen, Y.C.; Lu, J.J.; Wu, J.J.; Ho, S.W. Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan. Antimicrob. Agents. Chemother. 2000, 44, 3374-3380.
38. Oh, W.S.; Ko, K.S.; Song, J.H.; Lee, M.Y.; Park, S.; Peck, K.R.; Lee, N.Y.; Kim, C.K.; Lee, H.; Kim, S.W. et al. High rate of resistance to quinupristin-dalfopristin in Enterococcus faecium clinical isolates from Korea. Antimicrob. Agents. Chemother. 2005, 49, 5176-5178.
39. Wang, L.L.; Yang, X.Y.; Li, G.; Li, X.Y.; Jia, W. Clinical distribution of enterococci infection and drug resistance. Chin. J. Nasocomiol. 2011, 21, 1043-1045.
40. Xi, R.; Tian, S.F.; Chu, Y.Z.; Chen, B.Y. Linezolid induces resistance in Enterococcus in vitro and the mechanism. Chin. J. Infect. Chemother. 2011, 11, 22-26.
41. Brenwald, N.P.; Gill, M.J.; Wise, R. The effect of reserpine, an inhibitor of multi-drug efflux pumps, on the in vitro susceptibilities of fluoroquinolone-resistant strains of Streptococcus pneumoniae to norfloxacin. J. Antimicrob. Chemother. 1997, 40, 458-460.
42. Beyer, R.E.; Pestova, J.J.; Millichap, V.; Stosor, G.; Noskin, A.; Peterson, L.R. A convenient assay for estimating the possible involvement of efflux of fluoroquinolones by Streptococcus pneumoniae and Staphylococcus aureus: Evidence for diminished moxifloxacin, sparfloxacin, and trovafloxacin efflux. Antimicrob. Agents. Chemother. 2000, 44, 798-801.
43. Brenwald, N.P.; Gill, M.J.; Wise, R. Prevalence of a putative efflux mechanism among fluoroquinolone-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob. Agents. Chemother. 1998, 42, 2032-2035.
44. Markham, P.N. Inhibition of the emergence of ciprofloxacin resistance in Streptococcus pncumoiae by the multidrug efflux inhibitor reserpine. Antinicrob. Agents. Chemother. 1999, 43, 988-999.
45. Wilke, M.S.; Lovering, A.L.; Strynadka, N.C.J. β-Lactam antibiotic resistance: A current structural perspective. Curr. Opin. Microbiol. 2005, 8, 525-533.
46. Zapun, A.; Contreras-Martel, C.; Vernet, T. Penicillin-binding proteins and β-lactam resistance. FEMS. Microbiol. Rev. 2008, 32, 361-385.
47. Chow, J.W. Aminoglycoside resistance in enterococci. Clin. Infect. Dis. 2000, 31, 586-589.
48. Daigle, D.M.; Hughes, D.W.; Wright, G.D. Prodigious substrate specificity of AAC(6')-APH(2), an aminoglycoside antibiotic resistance determinant in enterococci and staphylococci. Chem. Biol. 1999, 6, 99-110.
49. Roberts, M.C. Tetracycline resistance determinants: Mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS. Microbiol. Rev. 1996, 19, 1-24.
50. Portillo, A.; Ruiz-Larrea, F.; Zarazaga, M.; Alonso, A.; Martinez, J.L.; Torres, C. Macrolide resistance genes in Enterococcus spp. Antimicrob. Agents Chemother. 2000, 44, 967-971.
51. Leclercq, R. Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 2002, 34, 482-492.
52. Reyes, J.; Hidalgo, M.; Díaz, L.; Rincón, S.; Moreno, J.; Vanegas, N.; Castañeda E; Arias, C.A. Characterization of macrolide resistance in Gram-positive cocci from Colombian hospitals: A countrywide surveillance. Int. J. Infect. Dis. 2007, 11, 329-336.
53. Martel, A.; Devriese, L.A.; Decostere, A.; Haesebrouck, F. Presence of macrolide resistance genes in streptococci and enterococci isolated from pigs and pork carcasses. Int. J. Food Microbiol. 2003, 84, 27-32.
54. Liang, Q.H.; Xu, Y.J.; Liu, C.L.; Zeng, L.W. Analysis of antimicrobial resistance and antimicrobial resistance genes in 53 clinically isolated enterococcal isolates. J. Trop. Med. 2012, 12, 1458-1461.
55. Arthur, M.; Reynolds, P.; Courvalin, P. Glycopeptide resistance in enterococci. Trends Microbiol. 1996, 4, 401-407.
56. Arthur, M.; Courvalin, P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents. Chemother. 1993, 37, 1563-1571.
57. Kauffman, C.A. Therapeutic and preventative options for the management of vancomycin-resistant enterococcal infections. J. Antimicrob. Chemother. 2003, 51, 23-30.